HK Tech & Health Business: ReNerve Ltd signed an exclusive three-year distribution deal with STC to commercialise its NervAlign products across Hong Kong, Macau and the Greater Bay Area, with STC handling import, warehousing, marketing, sales and distribution while ReNerve provides clinical support and regulatory liaison. AI Finance & Markets: Hong Kong Investment Corporation (HKIC) says it already bypassed the J-curve, posting HK$2.3b in 2024 and double-digit returns in 2025, as lawmakers discuss a potential funding injection. Digital Currency Push: China is expanding e-CNY use via incentives for banks and directives for payments, trade and even fiscal spending, including cross-border products tied to Belt and Road routes. Hong Kong Tech Ecosystem: HKPC and DHL Express Hong Kong will co-host an SME-focused “Blueprint for Global Expansion” forum on 12 June, targeting barriers like customs complexity and logistics costs. Biotech Deal: Pfizer and Innovent Biologics ink a deal worth up to $10.5b to develop cancer drugs, with an upfront $650m. New Medical Leadership: HKUST appoints Prof. LI King-Chuen as founding dean of its School of Medicine, aiming to blend engineering, data science and biomedical innovation. Markets Mood: Asia stocks firmed as AI-linked shares rallied, while oil rose on US-Iran and Middle East uncertainty. Corporate Tech Funding: Big Tech hyperscalers are issuing large corporate debt in Europe and other currencies to fund AI infrastructure like data centers.